2023 annual financial data
Nurix Therapeutics 2023 Operating cash flow margin
Direct answer
Operating cash flow margin was -105.69%.
Operating income was -155,063,000 USD and net income was -143,948,000 USD.
Operating cash flow was -81,365,000 USD.
Get free Nurix Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 76,987,000 USD
- Operating income
- -155,063,000 USD
- Net income
- -143,948,000 USD
- Operating cash flow
- -81,365,000 USD